ID

22184

Description

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Mots-clés

  1. 22/05/2017 22/05/2017 -
Téléchargé le

22 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Prior Medication
Description

Prior Medication

Alias
UMLS CUI-1
C0013227
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
Description

Pharmaceutical preparations

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
If ´YES`, please record the medications below.
Description

specification

Type de données

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2348235
Prior Medication
Description

Prior Medication

Alias
UMLS CUI-1
C2826257
Drug name (Trade Name preferred)
Description

Drug name

Type de données

text

Alias
UMLS CUI [1]
C0013227
Single Dose/ Unit (e.g. 500mg)
Description

Single dose/Unit

Type de données

float

Unités de mesure
  • mg
Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
mg
Frequency of this Dose (e.g. BID PRN)
Description

Frequency

Type de données

text

Alias
UMLS CUI [1]
C3476109
Route
Description

Route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Indication
Description

Indication

Type de données

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
End Date
Description

End Date

Type de données

date

Unités de mesure
  • Day Month Year
Alias
UMLS CUI [1]
C1531784
Day Month Year
Continuing at end of
Description

Continuing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1553904

Similar models

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Prior Medication
C0013227 (UMLS CUI-1)
Pharmaceutical preparations
Item
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C0013227 (UMLS CUI [1])
specification
Item
If ´YES`, please record the medications below.
text
C0013227 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item Group
Prior Medication
C2826257 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
Single Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
End Date
Item
End Date
date
C1531784 (UMLS CUI [1])
Continuing
Item
Continuing at end of
boolean
C0087111 (UMLS CUI [1,1])
C1553904 (UMLS CUI [1,2])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial